Chembio Diagnostics Inc
NASDAQ:CEMI
Chembio Diagnostics Inc
Operating Income
Chembio Diagnostics Inc
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Chembio Diagnostics Inc
NASDAQ:CEMI
|
Operating Income
-$20.4m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
N/A
|
|
Haemonetics Corp
NYSE:HAE
|
Operating Income
$199.3m
|
CAGR 3-Years
24%
|
CAGR 5-Years
13%
|
CAGR 10-Years
4%
|
|
Cooper Companies Inc
NYSE:COO
|
Operating Income
$536.7m
|
CAGR 3-Years
17%
|
CAGR 5-Years
5%
|
CAGR 10-Years
5%
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Operating Income
$296m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-4%
|
|
Align Technology Inc
NASDAQ:ALGN
|
Operating Income
$663.9m
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
14%
|
See Also
What is Chembio Diagnostics Inc's Operating Income?
Operating Income
-20.4m
USD
Based on the financial report for Dec 31, 2022, Chembio Diagnostics Inc's Operating Income amounts to -20.4m USD.
What is Chembio Diagnostics Inc's Operating Income growth rate?
Operating Income CAGR 5Y
-26%
Over the last year, the Operating Income growth was 15%. The average annual Operating Income growth rates for Chembio Diagnostics Inc have been -17% over the past three years , -26% over the past five years .